NCT06379308 Anterior Cruciate Ligament (ACL) Revision Surgery: French National Study
| NCT ID | NCT06379308 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Anterior Cruciate Ligament Rupture |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-01-01 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a national multicentric study led by the French Arthroscopy Society (SFA) evaluating clinical practice in anterior cruciate ligament (ACL) revision surgery (epidemiological data, morphological data, operative data, clinical and functional outcomes, and surgical complication rates).
Eligibility Criteria
Inclusion Criteria: * Patient with an anterior cruciate ligament (ACL) revision, defined as "all surgical procedures involving replacement of the anterior cruciate ligament (ACL) graft with a new graft". Exclusion Criteria: * multil-igament injuries * any procedure where the ACL was not revised and where any additional graft was inserted * Patients who had already undergone their first revision anterior cruciate ligament (ACL) procedure
Contact & Investigator
Thomas NERI, MD PhD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT06379308 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anterior Cruciate Ligament Rupture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06379308 currently recruiting?
Yes, NCT06379308 is actively recruiting participants. Contact the research team at thomas.neri@chu-st-etienne.fr for enrollment information.
Where is the NCT06379308 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT06379308 clinical trial?
NCT06379308 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Thomas NERI, MD PhD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 300 participants.